Brace Pharma Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
1
- Investments
-
29
- Portfolio
-
5
- Exits
-
13
Brace Pharma Capital General Information
Company Description
Founded in 2013, Brace Pharma Capital is the corporate venture capital arm of EMS based in Atlanta, Georgia. The firm prefers to invest in healthcare, life sciences, and oncology sector firms based in Brazil.
Business Details
Website
www.bracepharma.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 387 Technology Circle NorthWest
- Suite 225
- Atlanta, GA 30313
- United States
Brace Pharma Capital Investments (29)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| F2G | 12-Sep-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Antiva Biosciences | 02-Nov-2021 | Drug Discovery | Generating Revenue | |||
| Turnstone Biologics | 14-Jul-2021 | Biotechnology | Generating Revenue | |||
| Contineum Therapeutics | 11-Feb-2021 | Drug Discovery | Generating Revenue | |||
| ReViral | 25-Aug-2020 | Drug Discovery | Clinical Trials - Phase 2 | |||
| F2G | 12-Aug-2020 | Drug Discovery | Clinical Trials - Phase 2 | |||
| HotSpot Therapeutics | 21-May-2020 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Contineum Therapeutics | 18-Dec-2019 | Drug Discovery | Generating Revenue | |||
| Avidity Biosciences | 13-Nov-2019 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| F2G | 01-Nov-2019 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 |
Brace Pharma Capital Exits (13)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Gliknik | 01-Feb-2026 | Secondary Transaction - Private | |
| Navitor Pharmaceuticals | 25-Oct-2024 | ||
| Contineum Therapeutics | 05-Apr-2024 | ||
| Turnstone Biologics | 21-Jul-2023 | ||
| ReViral | 06-Apr-2022 | ||
| Avidity Biosciences | 12-Jun-2020 | ||
| Precision BioSciences | 28-Mar-2019 | ||
| Therabron Therapeutics | 01-Nov-2018 | ||
| AVROBIO | 21-Jun-2018 | IPO | |
| Cogent Biosciences | 29-Mar-2018 | IPO |
Brace Pharma Capital Investments by Industry, Year, and Region
Brace Pharma Capital Co-Investors (13)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Forbion | 1 |
|
|
||
| ICG |
|
|
|||
| Merifin Capital |
|
|
|||
| Novo Holdings |
|
|
|||
| Shionogi |
|
|
Brace Pharma Capital FAQs
-
What is Brace Pharma Capital?
Founded in 2013, Brace Pharma Capital is the corporate venture capital arm of EMS based in Atlanta, Georgia.
-
When was Brace Pharma Capital founded?
Brace Pharma Capital was founded in 2013.
-
Where is Brace Pharma Capital headquartered?
Brace Pharma Capital is headquartered in Atlanta, GA.
-
How many investments has Brace Pharma Capital made?
Brace Pharma Capital has made 29 investments.
-
What has Brace Pharma Capital invested in?
Brace Pharma Capital has made numerous investments in companies like F2G, Antiva Biosciences, and Turnstone Biologics within the Drug Discovery and Biotechnology industries.
-
What has Brace Pharma Capital invested in recently?
Brace Pharma Capital's latest investment was on 12-Sep-2024 in F2G, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process